703 related articles for article (PubMed ID: 26341564)
1. Seroepidemiological study of hepatitis B virus markers in Japan.
Kiyohara T; Ishii K; Mizokami M; Sugiyama M; Wakita T
Vaccine; 2015 Nov; 33(45):6037-42. PubMed ID: 26341564
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological serosurvey of hepatitis B virus among children aged 1-14 years in Guangdong Province, China.
Zhu Q; Shao X; Chen S; Li D; Chen X; Liu W; Wu X; Jian Z; Rutherford S; Zheng H
Int J Infect Dis; 2018 Jun; 71():25-29. PubMed ID: 29408358
[TBL] [Abstract][Full Text] [Related]
3. Continuing Decrease in Hepatitis B Virus Infection 30 Years After Initiation of Infant Vaccination Program in Taiwan.
Ni YH; Chang MH; Jan CF; Hsu HY; Chen HL; Wu JF; Chen DS
Clin Gastroenterol Hepatol; 2016 Sep; 14(9):1324-30. PubMed ID: 27155556
[TBL] [Abstract][Full Text] [Related]
4. Seroepidemiology of hepatitis B in Greek children 6 years after the implementation of universal vaccination.
Papaevangelou V; Hadjichristodoulou C; Cassimos DC; Pantelaki K; Tzivaras A; Hatzimichael A; Theodoridou M
Infection; 2008 Mar; 36(2):135-9. PubMed ID: 18231718
[TBL] [Abstract][Full Text] [Related]
5. The decline of hepatitis B viral infection in South-Western Saudi Arabia.
Ayoola AE; Tobaigy MS; Gadour MO; Ahmad BS; Hamza MK; Ageel AM
Saudi Med J; 2003 Sep; 24(9):991-5. PubMed ID: 12973485
[TBL] [Abstract][Full Text] [Related]
6. Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.
Aghasadeghi MR; Velayati AA; Mamishi S; Nabavi M; Aghakhani A; Bidari-Zerehpoosh F; Haghi Ashtiani MT; Sabeti S; Banifazl M; Azimian-Zavareh F; Motevalli F; Soleymani S; Ramezani A
Arch Virol; 2016 Dec; 161(12):3405-3411. PubMed ID: 27613286
[TBL] [Abstract][Full Text] [Related]
7. Markers of hepatitis B infection in Tari District, Southern Highlands Province, Papua New Guinea.
Sanders RC; Lewis D; Dyke T; Alpers MP
P N G Med J; 1992 Sep; 35(3):197-201. PubMed ID: 1296422
[TBL] [Abstract][Full Text] [Related]
8. Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination.
Lai MW; Lin TY; Tsao KC; Huang CG; Hsiao MJ; Liang KH; Yeh CT
Gastroenterology; 2012 Aug; 143(2):400-7. PubMed ID: 22580098
[TBL] [Abstract][Full Text] [Related]
9. Impact of hepatitis B vaccination among children in Guangdong Province, China.
Xiao J; Zhang J; Wu C; Shao X; Peng G; Peng Z; Ma W; Zhang Y; Zheng H
Int J Infect Dis; 2012 Sep; 16(9):e692-6. PubMed ID: 22795176
[TBL] [Abstract][Full Text] [Related]
10. Seroepidemiology of hepatitis B virus infection among children in Mongolia: results of a nationwide survey.
Davaalkham D; Ojima T; Nymadawa P; Tsend N; Lkhagvasuren T; Wiersma S; Uehara R; Watanabe M; Oki I; Nakamura Y
Pediatr Int; 2007 Jun; 49(3):368-74. PubMed ID: 17532838
[TBL] [Abstract][Full Text] [Related]
11. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
[TBL] [Abstract][Full Text] [Related]
12. [Preliminary analysis on the prevalence and causes of breakthrough hepatitis B virus infection among children in Shandong province, China].
Zhang L; Yan BY; Li MS; Song LZ; Lü JJ; Xu Q; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Oct; 47(10):933-9. PubMed ID: 24378135
[TBL] [Abstract][Full Text] [Related]
13. An epidemiological serosurvey of hepatitis B virus shows evidence of declining prevalence due to hepatitis B vaccination in central China.
Yonghao G; Jin X; Jun L; Pumei D; Ying Y; Xiuhong F; Yanyang Z; Wanshen G
Int J Infect Dis; 2015 Nov; 40():75-80. PubMed ID: 26456567
[TBL] [Abstract][Full Text] [Related]
14. [Hepatitis B prevalence among women in child-bearing age in Shandong Province, China, 2014].
Zhang L; Liu JY; Lyu JJ; Yan BY; Feng Y; Wu WL; Song LZ; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):475-479. PubMed ID: 28592088
[No Abstract] [Full Text] [Related]
15. [Seroepidemiological analysis of hepatitis B among children aged 1-14 in 3 counties of Guangdong province in 2013].
Shao X; Wu C; Wang F; Liang J; Xie X; Zhu Q; Liu J; Hu P; Qiu Q; Liang X; Zheng H
Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Sep; 49(9):777-81. PubMed ID: 26733134
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program.
Peto TJ; Mendy ME; Lowe Y; Webb EL; Whittle HC; Hall AJ
BMC Infect Dis; 2014 Jan; 14():7. PubMed ID: 24397793
[TBL] [Abstract][Full Text] [Related]
17. Minimization of hepatitis B infection by a 25-year universal vaccination program.
Ni YH; Chang MH; Wu JF; Hsu HY; Chen HL; Chen DS
J Hepatol; 2012 Oct; 57(4):730-5. PubMed ID: 22668640
[TBL] [Abstract][Full Text] [Related]
18. [Comparative analyze on hepatitis B seroepidemiological surveys among population aged 1-29 years in different epidemic regions of China in 1992 and 2014].
Wang FZ; Zhang GM; Shen LP; Zheng H; Wang F; Miao N; Yuan QL; Sun XJ; Bi SL; Liang XF; Wang HQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):462-468. PubMed ID: 28592086
[No Abstract] [Full Text] [Related]
19. Hepatitis B vaccination in children: the Taiwan experience.
Ni YH; Chen DS
Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
[TBL] [Abstract][Full Text] [Related]
20. Seroepidemiology of hepatitis B virus infection and impact of vaccination.
Huang P; Zhu LG; Zhu YF; Yue M; Su J; Zhu FC; Yang HT; Zhang Y; Shen HB; Yu RB; Zhai XJ; Peng ZH
World J Gastroenterol; 2015 Jul; 21(25):7842-50. PubMed ID: 26167084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
